000 | 01875 a2200505 4500 | ||
---|---|---|---|
005 | 20250516200110.0 | ||
264 | 0 | _c20150226 | |
008 | 201502s 0 0 eng d | ||
022 | _a1536-4844 | ||
024 | 7 |
_a10.1097/01.MIB.0000442839.28664.75 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCollins, Colm B | |
245 | 0 | 0 |
_aTargeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation. _h[electronic resource] |
260 |
_bInflammatory bowel diseases _cApr 2014 |
||
300 |
_a685-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAdenosine Triphosphatases _xantagonists & inhibitors |
650 | 0 | 4 | _aAdoptive Transfer |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCell Nucleus _xchemistry |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 |
_aColitis _xchemically induced |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aDextran Sulfate |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIleitis _xdrug therapy |
650 | 0 | 4 |
_aIntestinal Mucosa _ximmunology |
650 | 0 | 4 | _aJurkat Cells |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNovobiocin _xtherapeutic use |
650 | 0 | 4 |
_aTranscription Factor RelA _xanalysis |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
700 | 1 | _aStrassheim, Derek | |
700 | 1 | _aAherne, Carol M | |
700 | 1 | _aYeckes, Alyson R | |
700 | 1 | _aJedlicka, Paul | |
700 | 1 | _ade Zoeten, Edwin F | |
773 | 0 |
_tInflammatory bowel diseases _gvol. 20 _gno. 4 _gp. 685-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.MIB.0000442839.28664.75 _zAvailable from publisher's website |
999 |
_c23570251 _d23570251 |